Detection of HPV infection in head and neck cancers: Promise and pitfalls in the last ten years - a meta-analysis
- Authors:
- Carolin Götz
- Clara Bischof
- Klaus-Dietrich Wolff
- Andreas Kolk
-
Affiliations: Department of Oral and Maxillofacial Surgery, Technical University of Munich, Klinikum Rechts der Isar, D-81675 Munich, Germany - Published online on: October 22, 2018 https://doi.org/10.3892/mco.2018.1749
- Pages: 17-28
-
Copyright: © Götz et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. J Int Cancer. 127:2893–2917. 2010. View Article : Google Scholar | |
Kaatsch P, Spix C, Katalinic A, Hentschel S, Luttmann S and Stegmaier C: Cancer in Germany 2011/2012. Robert Koch Institute and the Society of Epidemiological Cancer Registries in Germany. Robert-Koch-Institut; Berlin: 2015, (In German). | |
Licitra L, Zigon G, Gatta G, Sanchez MJ and Berrino F: Human papillomavirus in HNSCC: A European epidemiologic perspective. Hematol Oncol Clin North Am. 22:1143–1153, vii-viii. 2008. View Article : Google Scholar : PubMed/NCBI | |
Chaturvedi AK, Engels EA, Anderson WF and Gillison ML: Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 26:612–619. 2008. View Article : Google Scholar : PubMed/NCBI | |
Syrjänen KJ, Pyrhönen S, Syrjänen SM and Lamberg MA: Immunohistochemical demonstration of human papilloma virus (HPV) antigens in oral squamous cell lesions. Br J Oral Surg. 21:147–153. 1983. View Article : Google Scholar : PubMed/NCBI | |
World Health Organization; International Agency for Research on Cancer: Human Papillomaviruses. IARc Monographs on the Evaluation of Carcinogenic Risks to Humans. 90. IARC; Lyon: pp. 1–636. 2007, PubMed/NCBI | |
Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, et al: Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 29:4294–4301. 2011. View Article : Google Scholar : PubMed/NCBI | |
Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V and Roberts S: Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck. 35:747–755. 2013. View Article : Google Scholar : PubMed/NCBI | |
Stein AP, Saha S, Yu M, Kimple RJ and Lambert PF: Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the United States across time. Chem Res Toxicol. 27:462–469. 2014. View Article : Google Scholar : PubMed/NCBI | |
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J and Moher D: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 6:e10001002009. View Article : Google Scholar : PubMed/NCBI | |
Moher D1, Liberati A, Tetzlaff J and Altman DG; PRISMA Group, . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 151:264–269. 2009. View Article : Google Scholar : PubMed/NCBI | |
Al-Swiahb JN, Huang CC, Fang FM, Chuang HC, Huang HY, Luo SD, Chen CH, Chen CM and Chien CY: Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area. Arch Otolaryngol Head Neck Surg. 136:502–508. 2010. View Article : Google Scholar : PubMed/NCBI | |
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI | |
Baumeister P, Reiter M, Welz C, Becker S, Betz C and Harréus U: Surgically treated oropharyngeal cancer: Risk factors and tumor characteristics. J Cancer Res Clin Oncol. 140:1011–1019. 2014. View Article : Google Scholar : PubMed/NCBI | |
Bledsoe TJ, Noble AR, Hunter GK, Rybicki LA, Hoschar A, Chute DJ, Saxton JP, Greskovich JF, Adelstein DJ and Koyfman SA: Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: Patterns of failure and toxicity outcomes. Radiat Oncol. 8:1742013. View Article : Google Scholar : PubMed/NCBI | |
Bossi P, Orlandi E, Miceli R, Perrone F, Guzzo M, Mariani L, Granata R, Locati L, Fallai C, Cortelazzi B, Pilotti S, et al: Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis. Ann Oncol. 25:694–699. 2014. View Article : Google Scholar : PubMed/NCBI | |
Broglie MA, Soltermann A, Rohrbach D, Haile SR, Pawlita M, Studer G, Huber GF, Moch H and Stoeckli SJ: Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation. Head Neck. 35:1698–1706. 2013. View Article : Google Scholar : PubMed/NCBI | |
Bussu F, Sali M, Gallus R, Petrone G, Zannoni GF, Autorino R, Dinapoli N, Santangelo R, Vellone VG, Graziani C, et al: Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: Detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators-a pilot study. Int J Radiat Oncol Biol Phys. 89:1115–1120. 2014. View Article : Google Scholar : PubMed/NCBI | |
Cerezo L, López C, de la Torre A, Suárez D, Hervás A, Ruiz A, Ballestín C, Martín M and Sandoval P: Incidence of human papillomavirus-related oropharyngeal cancer and outcomes after chemoradiation in a population of heavy smokers. Head Neck. 36:782–786. 2014. View Article : Google Scholar : PubMed/NCBI | |
Charfi L, Jouffroy T, de Cremoux P, Le Peltier N, Thioux M, Fréneaux P, Point D, Girod A, Rodriguez J and Sastre-Garau X: Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer Lett. 260:72–78. 2008. View Article : Google Scholar : PubMed/NCBI | |
Chernock RD, Zhang Q, El-Mofty SK, Thorstad WL and Lewis JS Jr: Human papillomavirus-related squamous cell carcinoma of the oropharynx: A comparative study in whites and African Americans. Arch Otolaryngol Head Neck Surg. 137:163–169. 2011. View Article : Google Scholar : PubMed/NCBI | |
Chien CY, Su CY, Fang FM, Huang HY, Chuang HC, Chen CM and Huang CC: Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol. 44:174–179. 2008. View Article : Google Scholar : PubMed/NCBI | |
Cohen MA, Weinstein GS, O'Malley BW Jr, Feldman M and Quon H: Transoral robotic surgery and human papillomavirus status: Oncologic results. Head Neck. 33:573–580. 2011. View Article : Google Scholar : PubMed/NCBI | |
D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH and Gillison ML: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 356:1944–1956. 2007. View Article : Google Scholar : PubMed/NCBI | |
Ernster JA, Sciotto CG, O'Brien MM, Finch JL, Robinson LJ, Willson T and Mathews M: Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope. 117:2115–2128. 2007. View Article : Google Scholar : PubMed/NCBI | |
Evans M, Newcombe R, Fiander A, Powell J, Rolles M, Thavaraj S, Robinson M and Powell N: Human Papillomavirus-associated oropharyngeal cancer: An observational study of diagnosis, prevalence and prognosis in a UK population. BMC Cancer. 13:2202013. View Article : Google Scholar : PubMed/NCBI | |
Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA, et al: Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol. 32:3365–3373. 2014. View Article : Google Scholar : PubMed/NCBI | |
Fallai C, Perrone F, Licitra L, Pilotti S, Locati L, Bossi P, Orlandi E, Palazzi M and Olmi P: Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: Prognostic role of TP53 and HPV status. Int J Radiat Oncol Biol Phys. 75:1053–1059. 2009. View Article : Google Scholar : PubMed/NCBI | |
Fei J, Hong A, Dobbins TA, Jones D, Lee CS, Loo C, Al-Ghamdi M, Harnett GB, Clark J, O'Brien CJ, et al: Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor. Ann Surg Oncol. 16:2908–2917. 2009. View Article : Google Scholar : PubMed/NCBI | |
Fischer CA, Kampmann M, Zlobec I, Green E, Tornillo L, Lugli A, Wolfensberger M and Terracciano LM: p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol. 21:1961–1966. 2010. View Article : Google Scholar : PubMed/NCBI | |
Geiger JL, Lazim AF, Walsh FJ, Foote RL, Moore EJ, Okuno SH, Olsen KD, Kasperbauer JL, Price DL, Garces YI, et al: Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma. Oral Oncol. 50:311–318. 2014. View Article : Google Scholar : PubMed/NCBI | |
Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, Spencer S, Harris J, Chung CH and Ang KK: Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol. 30:2102–2111. 2012. View Article : Google Scholar : PubMed/NCBI | |
Hafkamp HC, Manni JJ, Haesevoets A, Voogd AC, Schepers M, Bot FJ, Hopman AH, Ramaekers FC and Speel EJ: Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer. 122:2656–2664. 2008. View Article : Google Scholar : PubMed/NCBI | |
Hama T, Tokumaru Y, Fujii M, Yane K, Okami K, Kato K, Masuda M, Mineta H, Nakashima T, Sugasawa M, et al: Prevalence of human papillomavirus in oropharyngeal cancer: A multicenter study in Japan. Oncology. 87:173–182. 2014. View Article : Google Scholar : PubMed/NCBI | |
Hannisdal K, Schjølberg A, De Angelis PM, Boysen M and Clausen OP: Human papillomavirus (HPV)-positive tonsillar carcinomas are frequent and have a favourable prognosis in males in Norway. Acta Otolaryngol. 130:293–299. 2010. View Article : Google Scholar : PubMed/NCBI | |
Hong A, Dobbins T, Lee CS, Jones D, Jackson E, Clark J, Armstrong B, Harnett G, Milross C, O'Brien C and Rose B: Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer. Eur J Cancer. 46:2088–2096. 2010. View Article : Google Scholar : PubMed/NCBI | |
Hong AM, Dobbins TA, Lee CS, Jones D, Harnett GB, Armstrong BK, Clark JR, Milross CG, Kim J, O'Brien CJ, et al: Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer. 103:1510–1517. 2010. View Article : Google Scholar : PubMed/NCBI | |
Huang H, Zhang B, Chen W, Zhou SM, Zhang YX, Gao L, Xu ZG, Qiao YL and Tang PZ: Human papillomavirus infection and prognostic predictors in patients with oropharyngeal squamous cell carcinoma. Asian Pac J Cancer Prev. 13:891–896. 2012. View Article : Google Scholar : PubMed/NCBI | |
Isayeva T, Xu J, Dai Q, Whitley AC, Bonner J, Nabell L, Spencer S, Carroll W, Jones G, Ragin C, et al: African Americans with oropharyngeal carcinoma have significantly poorer outcomes despite similar rates of human papillomavirus-mediated carcinogenesis. Hum Pathol. 45:310–319. 2014. View Article : Google Scholar : PubMed/NCBI | |
Joo YH, Cho KJ, Park JO, Nam IC and Kim MS: Factors influencing the outcomes of primary surgery with postoperative radiotherapy for pN2 oropharyneal squamous cell carcinoma. Oral Oncol. 48:90–94. 2012. View Article : Google Scholar : PubMed/NCBI | |
Jung AC, Briolat J, Millon R, de Reyniès A, Rickman D, Thomas E, Abecassis J, Clavel C and Wasylyk B: Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. International journal of cancer. Int J Cancer. 126:1882–1894. 2010. View Article : Google Scholar : PubMed/NCBI | |
Junor E, Kerr G, Oniscu A, Campbell S, Kouzeli I, Gourley C and Cuschieri K: Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx. Br J Cancer. 106:358–365. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kawakami H, Okamoto I, Terao K, Sakai K, Suzuki M, Ueda S, Tanaka K, Kuwata K, Morita Y, Ono K, et al: Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer Med. 2:933–941. 2013. View Article : Google Scholar : PubMed/NCBI | |
Klussmann JP, Mooren JJ, Lehnen M, Claessen SM, Stenner M, Huebbers CU, Weissenborn SJ, Wedemeyer I, Preuss SF, Straetmans JM and Manni JJ: Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res. 15:1779–1786. 2009. View Article : Google Scholar : PubMed/NCBI | |
Kuo KT, Hsiao CH, Lin CH, Kuo LT, Huang SH and Lin MC: The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome. Mod Pathol. 21:376–386. 2008. View Article : Google Scholar : PubMed/NCBI | |
Lewis JS Jr, Thorstad WL, Chernock RD, Haughey BH, Yip JH, Zhang Q and El-Mofty SK: p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol. 34:1088–1096. 2010. View Article : Google Scholar : PubMed/NCBI | |
Li W, Thompson CH, O'Brien CJ, McNeil EB, Scolyer RA, Cossart YE, Veness MJ, Walker DM, Morgan GJ and Rose BR: Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. International journal of cancer. Int J Cancer. 106:553–558. 2003. View Article : Google Scholar : PubMed/NCBI | |
Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, Oggionni M, Rossini C, Cantù G, Squadrelli M, et al: High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 24:5630–5636. 2006. View Article : Google Scholar : PubMed/NCBI | |
Lin BM, Wang H, D'Souza G, Zhang Z, Fakhry C, Joseph AW, Drake VE, Sanguineti G, Westra WH and Pai SI: Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma. Cancer. 119:3462–3471. 2013. View Article : Google Scholar : PubMed/NCBI | |
Lindquist D, Ahrlund-Richter A, Tarján M, Tot T and Dalianis T: Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer. Anticancer Res. 32:153–161. 2012.PubMed/NCBI | |
Lindquist D, Romanitan M, Hammarstedt L, Näsman A, Dahlstrand H, Lindholm J, Onelöv L, Ramqvist T, Ye W, Munck-Wikland E, et al: Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol. 1:350–355. 2007. View Article : Google Scholar : PubMed/NCBI | |
Ljøkjel B, Lybak S, Haave H, Olofsson J, Vintermyr OK and Aarstad HJ: The impact of HPV infection on survival in a geographically defined cohort of oropharynx squamous cell carcinoma (OPSCC) patients in whom surgical treatment has been one main treatment. Acta Otolaryngol. 134:636–645. 2014. View Article : Google Scholar : PubMed/NCBI | |
Marklund L, Näsman A, Ramqvist T, Dalianis T, Munck-Wikland E and Hammarstedt L: Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer. Cancer Med. 1:82–88. 2012. View Article : Google Scholar : PubMed/NCBI | |
Maxwell JH, Kumar B, Feng FY, Worden FP, Lee JS, Eisbruch A, Wolf GT, Prince ME, Moyer JS, Teknos TN, Chepeha DB, et al: Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res. 16:1226–1235. 2010. View Article : Google Scholar : PubMed/NCBI | |
Melkane AE, Auperin A, Saulnier P, Lacroix L, Vielh P, Casiraghi O, Msakni I, Drusch F and Temam S: Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas. Head Neck. 36:257–265. 2014. View Article : Google Scholar : PubMed/NCBI | |
Mizumachi T, Kano S, Sakashita T, Hatakeyama H, Suzuki S, Homma A, Oridate N and Fukuda S: Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma. Int J Clin Oncol. 18:824–828. 2013. View Article : Google Scholar : PubMed/NCBI | |
Näsman A, Nordfors C, Grün N, Munck-Wikland E, Ramqvist T, Marklund L, Lindquist D and Dalianis T: Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival. Cancer Med. 2:507–518. 2013. View Article : Google Scholar : PubMed/NCBI | |
Nichols AC, Dhaliwal SS, Palma DA, Basmaji J, Chapeskie C, Dowthwaite S, Franklin JH, Fung K, Kwan K, Wehrli B, et al: Does HPV type affect outcome in oropharyngeal cancer? J Otolaryngol Head Neck Surg. 42(9)2013. | |
Nichols AC, Palma DA, Dhaliwal SS, Tan S, Theuer J, Chow W, Rajakumar C, Um S, Mundi N, Berk S, et al: The epidemic of human papillomavirus and oropharyngeal cancer in a Canadian population. Curr Oncol. 20:212–219. 2013. View Article : Google Scholar : PubMed/NCBI | |
Nichols AC, Finkelstein DM, Faquin WC, Westra WH, Mroz EA, Kneuertz P, Begum S, Michaud WA, Busse PM, Clark JR and Rocco JW: Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer. Clin Cancer Res. 16:2138–2146. 2010. View Article : Google Scholar : PubMed/NCBI | |
O'Sullivan B, Huang SH, Perez-Ordonez B, Massey C, Siu LL, Weinreb I, Hope A, Kim J, Bayley AJ, Cummings B, et al: Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol. 103:49–56. 2012. View Article : Google Scholar : PubMed/NCBI | |
O'Sullivan B, Huang SH, Siu LL, Waldron J, Zhao H, Perez-Ordonez B, Weinreb I, Kim J, Ringash J, Bayley A, et al: Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol. 31:543–550. 2013. View Article : Google Scholar : PubMed/NCBI | |
Oguejiofor KK, Hall JS, Mani N, Douglas C, Slevin NJ, Homer J, Hall G and West CM: The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma. Clin Oncol (R Coll Radiol). 25:630–638. 2013. View Article : Google Scholar : PubMed/NCBI | |
Park K, Cho KJ, Lee M, Yoon DH, Kim J, Kim SY, Nam SY, Choi SH, Roh JL, Han MW, et al: p16 immunohistochemistry alone is a better prognosticator in tonsil cancer than human papillomavirus in situ hybridization with or without p16 immunohistochemistry. Acta Otolaryngol. 133:297–304. 2013. View Article : Google Scholar : PubMed/NCBI | |
Park WS, Ryu J, Cho KH, Choi MK, Moon SH, Yun T, Chun BS, Lee GK, Ahn HJ, Lee JH, et al: Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: Use of G1 cycle markers as new prognosticators. Head Neck. 34:1408–1417. 2012. View Article : Google Scholar : PubMed/NCBI | |
Posner MR, Lorch JH, Goloubeva O, Tan M, Schumaker LM, Sarlis NJ, Haddad RI and Cullen KJ: Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol. 22:1071–1077. 2011. View Article : Google Scholar : PubMed/NCBI | |
Psychogios G, Alexiou C, Agaimy A, Brunner K, Koch M, Mantsopoulos K, Tomppert A and Iro H: Epidemiology and survival of HPV-related tonsillar carcinoma. Cancer Med. 3:652–659. 2014. View Article : Google Scholar : PubMed/NCBI | |
Psychogios G, Mantsopoulos K, Agaimy A, Koch M, Zenk J, Waldfahrer F and Iro H: Prognostic factors in limited (T1-2, N0-1) oropharyngeal carcinoma treated with surgery ± adjuvant therapy. Head Neck. 35:1752–1758. 2013. View Article : Google Scholar : PubMed/NCBI | |
Rahmati R, Dogan S, Pyke O, Palmer F, Awad M, Lee N, Kraus DH, Shah JP, Patel SG and Ganly I: Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation. Head Neck. 37:800–807. 2014. View Article : Google Scholar : PubMed/NCBI | |
Reimers N, Kasper HU, Weissenborn SJ, Stützer H, Preuss SF, Hoffmann TK, Speel EJ, Dienes HP, Pfister HJ, Guntinas-Lichius O and Klussmann JP: Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 120:1731–1738. 2007. View Article : Google Scholar : PubMed/NCBI | |
Rietbergen MM, Brakenhoff RH, Bloemena E, Witte BI, Snijders PJ, Heideman DA, Boon D, Koljenovic S, Baatenburg-de Jong RJ and Leemans CR: Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann Oncol. 24:2740–2745. 2013. View Article : Google Scholar : PubMed/NCBI | |
Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O'Sullivan B, Kenny LM, et al: Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 28:4142–4148. 2010. View Article : Google Scholar : PubMed/NCBI | |
Rodrigo JP, Heideman DA, García-Pedrero JM, Fresno MF, Brakenhoff RH, Díaz Molina JP, Snijders PJ and Hermsen MA: Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990–2009). Int J Cancer. 134:487–492. 2014. View Article : Google Scholar : PubMed/NCBI | |
Schache AG, Liloglou T, Risk JM, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J, Woolgar JA, Helliwell TR, Triantafyllou A, Robinson M, Sloan P, et al: Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res. 17:6262–6271. 2011. View Article : Google Scholar : PubMed/NCBI | |
Sedaghat AR, Zhang Z, Begum S, Palermo R, Best S, Ulmer KM, Levine M, Zinreich E, Messing BP, Gold D, et al: Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope. 119:1542–1549. 2009. View Article : Google Scholar : PubMed/NCBI | |
Semrau R, Duerbaum H, Temming S, Huebbers C, Stenner M, Drebber U, Klussmann JP, Müller RP and Preuss SF: Prognostic impact of human papillomavirus status, survivin, and epidermal growth factor receptor expression on survival in patients treated with radiochemotherapy for very advanced nonresectable oropharyngeal cancer. Head Neck. 35:1339–1344. 2013. View Article : Google Scholar : PubMed/NCBI | |
Shi W, Kato H, Perez-Ordonez B, Pintilie M, Huang S, Hui A, O'Sullivan B, Waldron J, Cummings B, Kim J, et al: Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol. 27:6213–6221. 2009. View Article : Google Scholar : PubMed/NCBI | |
Song JS, Kim MS, Park JW, Lee YS and Kang CS: Expression of human papillomavirus-related proteins and its clinical implication in tonsillar squamous cell carcinoma. Korean J Pathol. 46:177–186. 2012. View Article : Google Scholar : PubMed/NCBI | |
Song X, Sturgis EM, Huang Z, Li X, Li C, Wei Q and Li G: Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy. Carcinogenesis. 35:62–68. 2014. View Article : Google Scholar : PubMed/NCBI | |
Straetmans JM, Olthof N, Mooren JJ, de Jong J, Speel EJ and Kremer B: Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas. Laryngoscope. 119:1951–1957. 2009. View Article : Google Scholar : PubMed/NCBI | |
Tural D, Eliçin O, Batur S, Arslan D, Öz B, Serdengeçti S and Uzel Ö: Human papillomavirus is independent prognostic factor on outcome of oropharyngeal squamous cell carcinoma. Tumour Biol. 34:3363–3369. 2013. View Article : Google Scholar : PubMed/NCBI | |
Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL and Lewis JS Jr: High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 35:1343–1350. 2011. View Article : Google Scholar : PubMed/NCBI | |
Ukpo OC, Pritchett CV, Lewis JE, Weaver AL, Smith DI and Moore EJ: Human papillomavirus-associated oropharyngeal squamous cell carcinomas: Primary tumor burden and survival in surgical patients. Ann Otol Rhinol Laryngol. 118:368–373. 2009. View Article : Google Scholar : PubMed/NCBI | |
Ward MJ, Mellows T, Harris S, Webb A, Patel NN, Cox HJ, Piper K, Ottensmeier CH, Thomas GJ and King EV: Staging and treatment of oropharyngeal cancer in the human papillomavirus era. Head Neck. 37:1002–1013. 2015. View Article : Google Scholar : PubMed/NCBI | |
Ward MJ, Thirdborough SM, Mellows T, Riley C, Harris S, Suchak K, Webb A, Hampton C, Patel NN, Randall CJ, et al: Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer. 110:489–500. 2014. View Article : Google Scholar : PubMed/NCBI | |
Weinberger PM, Merkley MA, Khichi SS, Lee JR, Psyrri A, Jackson LL and Dynan WS: Human papillomavirus-active head and neck cancer and ethnic health disparities. Laryngoscope. 120:1531–1537. 2010. View Article : Google Scholar : PubMed/NCBI | |
Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, et al: Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 24:736–747. 2006. View Article : Google Scholar : PubMed/NCBI | |
Worden FP, Kumar B, Lee JS, Wolf GT, Cordell KG, Taylor JM, Urba SG, Eisbruch A, Teknos TN, Chepeha DB, et al: Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: Response and survival positively associated with HPV16 copy number. J Clin Oncol. 26:3138–3146. 2008. View Article : Google Scholar : PubMed/NCBI | |
Worsham MJ1, Stephen JK, Chen KM, Mahan M, Schweitzer V, Havard S and Divine G: Improved survival with HPV among African Americans with oropharyngeal cancer. Clin Cancer Res. 19:2486–2492. 2013. View Article : Google Scholar : PubMed/NCBI | |
Young RJ, Rischin D, Fisher R, McArthur GA, Fox SB, Peters LJ, Corry J, Lim A, Waldeck K and Solomon B: Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 20:1230–1237. 2011. View Article : Google Scholar : PubMed/NCBI | |
Chen YW, Kao SY and Yang MH: Analysis of p16(INK4A) expression of oral squamous cell carcinomas in Taiwan: Prognostic correlation without relevance to betel quid consumption. J Surg Oncol. 106:149–154. 2012. View Article : Google Scholar : PubMed/NCBI | |
Duray A, Descamps G, Decaestecker C, Remmelink M, Sirtaine N, Lechien J, Ernoux-Neufcoeur P, Bletard N, Somja J, Depuydt CE, et al: Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope. 122:1558–1565. 2012. View Article : Google Scholar : PubMed/NCBI | |
Elango KJ, Suresh A, Erode EM, Subhadradevi L, Ravindran HK, Iyer SK, Iyer SK and Kuriakose MA: Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev. 12:889–896. 2011.PubMed/NCBI | |
Gröbe A, Hanken H, Kluwe L, Schöllchen M, Tribius S, Pohlenz P, Clauditz T, Grob T, Simon R, Sauter G, Heiland M and Blessmann M: Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma. J Oral Pathol Med. 42:676–681. 2013. View Article : Google Scholar : PubMed/NCBI | |
Huang SF, Li HF, Liao CT, Wang HM, Chen IH, Chang JT, Chen YJ and Cheng AJ: Association of HPV infections with second primary tumors in early-staged oral cavity cancer. Oral Dis. 18:809–815. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kozomara R, Jović N, Magić Z, Branković-Magić M and Minić V: p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival. J Craniomaxillofac Surg. 33:342–348. 2005. View Article : Google Scholar : PubMed/NCBI | |
Kruger M, Pabst AM, Walter C, Sagheb K, Günther C, Blatt S, Weise K, Al-Nawas B and Ziebart T: The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: A retrospective analysis of 88 patients and literature overview. J Craniomaxillofac Surg. 42:1506–1514. 2014. View Article : Google Scholar : PubMed/NCBI | |
Lee LA, Huang CG, Liao CT, Lee LY, Hsueh C, Chen TC, Lin CY, Fan KH, Wang HM, Huang SF, et al: Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One. 7:e407672012. View Article : Google Scholar : PubMed/NCBI | |
Lee LA, Huang CG, Tsao KC, Liao CT, Kang CJ, Chang KP, Huang SF, Chen IH, Fang TJ, Li HY, Yang SL, et al: Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes. J Clin Virol. 57:331–337. 2013. View Article : Google Scholar : PubMed/NCBI | |
Na II, Kang HJ, Cho SY, Koh JS, Lee JK, Lee BC, Lee GH, Lee YS, Yoo HJ, Ryoo BY, Yang SH and Shim YS: EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil. Eur J Cancer. 43:520–526. 2007. View Article : Google Scholar : PubMed/NCBI | |
Reuschenbach M, Kansy K, Garbe K, Vinokurova S, Flechtenmacher C, Toth C, Prigge ES, Thiele OC, Reinert S, Hoffmann J, et al: Lack of evidence of human papillomavirus-induced squamous cell carcinomas of the oral cavity in southern Germany. Oral Oncol. 49:937–942. 2013. View Article : Google Scholar : PubMed/NCBI | |
Sugiyama M, Bhawal UK, Kawamura M, Ishioka Y, Shigeishi H, Higashikawa K and Kamata N: Human papillomavirus-16 in oral squamous cell carcinoma: Clinical correlates and 5-year survival. Br J Oral Maxillofac Surg. 45:116–122. 2007. View Article : Google Scholar : PubMed/NCBI | |
Zhao D, Xu QG, Chen XM and Fan MW: Human papillomavirus as an independent predictor in oral squamous cell cancer. Int J Oral Sci. 1:119–125. 2009. View Article : Google Scholar : PubMed/NCBI | |
Ankola AA, Smith RV, Burk RD, Prystowsky MB, Sarta C and Schlecht NF: Comorbidity, human papillomavirus infection and head and neck cancer survival in an ethnically diverse population. Oral Oncol. 49:911–917. 2013. View Article : Google Scholar : PubMed/NCBI | |
Annertz K, Rosenquist K, Andersson G, Jacobsson H, Hansson BG and Wennerberg J: High-risk HPV and survival in patients with oral and oropharyngeal squamous cell carcinoma - 5-year follow up of a population-based study. Acta Otolaryngol. 134:843–851. 2014. View Article : Google Scholar : PubMed/NCBI | |
Badaracco G, Rizzo C, Mafera B, Pichi B, Giannarelli D, Rahimi SS, Vigili MG and Venuti A: Molecular analyses and prognostic relevance of HPV in head and neck tumours. Oncol Rep. 17:931–939. 2007.PubMed/NCBI | |
Báez A, Almodóvar JI, Cantor A, Celestin F, Cruz-Cruz L, Fonseca S, Trinidad-Pinedo J and Vega W: High frequency of HPV16-associated head and neck squamous cell carcinoma in the Puerto Rican population. Head Neck. 26:778–784. 2004. View Article : Google Scholar : PubMed/NCBI | |
Deng Z, Hasegawa M, Aoki K, Matayoshi S, Kiyuna A, Yamashita Y, Uehara T, Agena S, Maeda H, Xie M, et al: A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma. Int J Oncol. 45:67–76. 2014. View Article : Google Scholar : PubMed/NCBI | |
Deng Z, Hasegawa M, Yamashita Y, Matayoshi S, Kiyuna A, Agena S, Uehara T, Maeda H and Suzuki M: Prognostic value of human papillomavirus and squamous cell carcinoma antigen in head and neck squamous cell carcinoma. Cancer Sci. 103:2127–2134. 2012. View Article : Google Scholar : PubMed/NCBI | |
Duray A, Descamps G, Decaestecker C, Sirtaine N, Gilles A, Khalifé M, Chantrain G, Depuydt CE, Delvenne P and Saussez S: Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomas. Oncol Rep. 30:371–376. 2013. View Article : Google Scholar : PubMed/NCBI | |
Fischer CA, Zlobec I, Green E, Probst S, Storck C, Lugli A, Tornillo L, Wolfensberger M and Terracciano LM: Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? Int J Cancer. 126:1256–1262. 2010.PubMed/NCBI | |
Gavid M, Pillet S, Pozzetto B, Oriol M, Dumollard JM, Timoshenko AP, Martin C and Prades JM: Human papillomavirus and head and neck squamous cell carcinomas in the South-East of France: Prevalence, viral expression, and prognostic implications. Acta Otolaryngol. 133:538–543. 2013. View Article : Google Scholar : PubMed/NCBI | |
Hoffmann M, Görögh T, Gottschlich S, Lohrey C, Rittgen W, Ambrosch P, Schwarz E and Kahn T: Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett. 218:199–206. 2005. View Article : Google Scholar : PubMed/NCBI | |
Joo YH, Jung CK, Sun DI, Park JO, Cho KJ and Kim MS: High-risk human papillomavirus and cervical lymph node metastasis in patients with oropharyngeal cancer. Head Neck. 34:10–14. 2012. View Article : Google Scholar : PubMed/NCBI | |
Klozar J, Koslabova E, Kratochvil V, Salakova M and Tachezy R: Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors. J Surg Oncol. 107:625–633. 2013. View Article : Google Scholar : PubMed/NCBI | |
Klozar J, Kratochvil V, Salakova M, Smahelova J, Vesela E, Hamsikova E, Betka J and Tachez R: HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol. 265 Suppl 1:S75–S82. 2008. View Article : Google Scholar : PubMed/NCBI | |
Kong CS, Narasimhan B, Cao H, Kwok S, Erickson JP, Koong A, Pourmand N and Le QT: The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 74:553–561. 2009. View Article : Google Scholar : PubMed/NCBI | |
Laco J, Nekvindova J, Novakova V, Celakovsky P, Dolezalova H, Tucek L, Vosmikova H, Vosmik M, Neskudlova T, Cermakova E, et al: Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status. Neoplasma. 59:398–408. 2012. View Article : Google Scholar : PubMed/NCBI | |
Lassen P, Eriksen JG, Krogdahl A, Therkildsen MH, Ulhøi BP, Overgaard M, Specht L, Andersen E, Johansen J, Andersen LJ, et al; Danish Head and Neck Cancer Group (DAHANCA), . The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial. Radiother Oncol. 100:49–55. 2011. View Article : Google Scholar : PubMed/NCBI | |
López RV, Levi JE, Eluf-Neto J, Koifman RJ, Koifman S, Curado MP, Michaluart-Junior P, Figueiredo DL, Saggioro FP, de Carvalho MB, et al: Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection. Cancer Causes Control. 25:461–471. 2014. View Article : Google Scholar : PubMed/NCBI | |
Lukesova E, Boucek J, Rotnaglova E, Salakova M, Koslabova E, Grega M, Eckschlager T, Rihova B, Prochazka B, Klozar J, et al: High level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas. BioMed Res Int. 2014:3039292014. View Article : Google Scholar : PubMed/NCBI | |
Rades D, Seibold ND, Gebhard MP, Noack F, Schild SE and Thorns C: Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN). Strahlenther Onkol. 187:626–632. 2011. View Article : Google Scholar : PubMed/NCBI | |
Rautava J, Kuuskoski J, Syrjanen K, Grenman R and Syrjanen S: HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas. J Clin Virol. 53:116–120. 2012. View Article : Google Scholar : PubMed/NCBI | |
Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP and Haugen TH: Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 104:336–344. 2003. View Article : Google Scholar : PubMed/NCBI | |
Rittà M, De Andrea M, Mondini M, Mazibrada J, Giordano C, Pecorari G, Garzaro M, Landolfo V, Schena M, Chiusa L, et al: Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head Neck. 31:318–327. 2009. View Article : Google Scholar : PubMed/NCBI | |
Rosenquist K, Wennerberg J, Annertz K, Schildt EB, Hansson BG, Bladström A and Andersson G: Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: Human papillomavirus and other risk factors. Acta Otolaryngol. 127:980–987. 2007. View Article : Google Scholar : PubMed/NCBI | |
Salazar CR, Anayannis N, Smith RV, Wang Y, Haigentz M Jr, Garg M, Schiff BA, Kawachi N, Elman J, Belbin TJ, Prystowsky MB, Burk RD and Schlecht NF: Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Int J Cancer. 135:2404–2412. 2014. View Article : Google Scholar : PubMed/NCBI | |
Salazar CR, Smith RV, Garg MK, Haigentz M Jr, Schiff BA, Kawachi N, Anayannis N, Belbin TJ, Prystowsky MB, Burk RD, et al: Human papillomavirus-associated head and neck squamous cell carcinoma survival: A comparison by tumor site and initial treatment. Head Neck Pathol. 8:77–87. 2014. View Article : Google Scholar : PubMed/NCBI | |
Settle K, Posner MR, Schumaker LM, Tan M, Suntharalingam M, Goloubeva O, Strome SE, Haddad RI, Patel SS, Cambell EV III, et al: Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila). 2:776–781. 2009. View Article : Google Scholar : PubMed/NCBI | |
Smith EM, Rubenstein LM, Haugen TH, Pawlita M and Turek LP: Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: A case for multifactor disease. J Oncol. 2012:5718622012. View Article : Google Scholar : PubMed/NCBI | |
Smith EM, Rubenstein LM, Hoffman H, Haugen TH and Turek LP: Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer. 5:42010. View Article : Google Scholar : PubMed/NCBI | |
Smith EM, Wang D, Rubenstein LM, Morris WA, Turek LP and Haugen TH: Association between p53 and human papillomavirus in head and neck cancer survival. Cancer Epidemiol Biomarkers Prev. 17:421–427. 2008. View Article : Google Scholar : PubMed/NCBI | |
Stephen JK, Divine G, Chen KM, Chitale D, Havard S and Worsham MJ: Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma. Cancer Clin Oncol. 2:51–61. 2013.PubMed/NCBI | |
Thibaudeau E, Fortin B, Coutlée F, Nguyen-Tan P, Weng X, Audet ML, Abboud O, Guertin L, Christopoulos A, Tabet J, et al: HPV prevalence and prognostic value in a prospective cohort of 255 patients with locally advanced HNSCC: A single-centre experience. Int J Otolaryngol. 2013:4378152013. View Article : Google Scholar : PubMed/NCBI | |
Alos L, Moyano S, Nadal A, Alobid I, Blanch JL, Ayala E, Lloveras B, Quint W, Cardesa A and Ordi J: Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer. 115:2701–2709. 2009. View Article : Google Scholar : PubMed/NCBI | |
Ernoux-Neufcoeur P, Arafa M, Decaestecker C, Duray A, Remmelink M, Leroy X, Herfs M, Somja J, Depuydt CE, Delvenne P, et al: Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. J Cancer Res Clin Oncol. 137:173–181. 2011. View Article : Google Scholar : PubMed/NCBI | |
Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A and Gillison ML: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 100:261–269. 2008. View Article : Google Scholar : PubMed/NCBI | |
Friedland P, Thomas A, Naran A, Amanuel B, Grieu-Iacopetta F, Carrello A, Harnett G, Meyer C and Phillips M: Human papillomavirus and gene mutations in head and neck squamous carcinomas. ANZ J Surg. 82:362–366. 2012. View Article : Google Scholar : PubMed/NCBI | |
Heath S, Willis V, Allan K, Purdie K, Harwood C, Shields P, Simcock R, Williams T and Gilbert DC: Clinically significant human papilloma virus in squamous cell carcinoma of the head and neck in UK practice. Clin Oncol (R Coll Radiol). 24:e18–23. 2012. View Article : Google Scholar : PubMed/NCBI | |
Joo YH, Lee YS, Cho KJ, Park JO, Nam IC, Kim CS, Kim SY and Kim MS: Characteristics and prognostic implications of high-risk HPV-associated hypopharyngeal cancers. PLoS One. 8:e787182013. View Article : Google Scholar : PubMed/NCBI | |
Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J and Overgaard J: Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 27:1992–1998. 2009. View Article : Google Scholar : PubMed/NCBI | |
Lau HY, Brar S, Klimowicz AC, Petrillo SK, Hao D, Brockton NT, Kong CS, Lees-Miller SP and Magliocco AM: Prognostic significance of p16 in locally advanced squamous cell carcinoma of the head and neck treated with concurrent cisplatin and radiotherapy. Head Neck. 33:251–256. 2011. View Article : Google Scholar : PubMed/NCBI | |
Rampias T, Pectasides E, Prasad M, Sasaki C, Gouveris P, Dimou A, Kountourakis P, Perisanidis C, Burtness B, Zaramboukas T, Rimm D, et al: Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype. Ann Oncol. 24:2124–2131. 2013. View Article : Google Scholar : PubMed/NCBI | |
Sethi S, Ali-Fehmi R, Franceschi S, Struijk L, van Doorn LJ, Quint W, Albashiti B, Ibrahim M and Kato I: Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study. Int J Cancer. 131:1179–1186. 2012. View Article : Google Scholar : PubMed/NCBI | |
Sivars L, Näsman A, Tertipis N, Vlastos A, Ramqvist T, Dalianis T, Munck-Wikland E and Nordemar S: Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome. Cancer Med. 3:376–384. 2014. View Article : Google Scholar : PubMed/NCBI | |
Śnietura M, Jaworska M, Pigłowski W, Goraj-Zając A, Woźniak G and and Lange D: High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx. Pol J Pathol. 61:133–139. 2010.PubMed/NCBI | |
Stephen JK, Chen KM, Shah V, Havard S, Lu M, Schweitzer VP, Gardner G and Worsham MJ: Human papillomavirus outcomes in an access-to-care laryngeal cancer cohort. Otolaryngol Head Neck Surg. 146:730–738. 2012. View Article : Google Scholar : PubMed/NCBI | |
Tribius S, Hoffmann AS, Bastrop S, Görögh T, Haag J, Röcken C, Clauditz T, Grob T, Wilczak W, Tennstedt P, et al: HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome. Oral Oncol. 48:1178–1184. 2012. View Article : Google Scholar : PubMed/NCBI | |
Weiss D, Koopmann M and Rudack C: Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma. Head Neck. 33:856–862. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kreimer AR, Clifford GM, Boyle P and Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev. 14:467–475. 2005. View Article : Google Scholar : PubMed/NCBI | |
Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM and Tsao AS: Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2:152010. View Article : Google Scholar : PubMed/NCBI | |
Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, Wollum A, Sanman E, Wulf S, Lopez AD, et al: Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA. 311:183–192. 2014. View Article : Google Scholar : PubMed/NCBI | |
Adelstein DJ, Ridge JA, Gillison ML, Chaturvedi AK, D'Souza G, Gravitt PE, Westra W, Psyrri A, Kast WM, Koutsky LA, Giuliano A, et al: Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck. 31:1393–1422. 2009. View Article : Google Scholar : PubMed/NCBI | |
Ragin CC and Taioli E: Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 121:1813–1820. 2007. View Article : Google Scholar : PubMed/NCBI | |
Götz C, Drecoll E, Straub M, Bissinger O, Wolff KD and Kolk A: Impact of HPV infection on oral squamous cell carcinoma. Oncotarget. 7:76704–76712. 2016. View Article : Google Scholar : PubMed/NCBI | |
Butz K, Geisen C, Ullmann A, Spitkovsky D and Hoppe-Seyler F: Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis. International journal of cancer. Journal international du cancer. 68:506–513. 1996. View Article : Google Scholar : PubMed/NCBI | |
Hafkamp HC, Speel EJ, Haesevoets A, et al: A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. International journal of cancer. Journal international du cancer. 107:394–400. 2003. View Article : Google Scholar : PubMed/NCBI | |
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, et al: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 92:709–720. 2000. View Article : Google Scholar : PubMed/NCBI | |
Ragin CC, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F and Gollin SM: 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer. 95:1432–1438. 2006. View Article : Google Scholar : PubMed/NCBI | |
Hoffmann TK, Arsov C, Schirlau K, Bas M, Friebe-Hoffmann U, Klussmann JP, Scheckenbach K, Balz V, Bier H and Whiteside TL: T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx. Int J Cancer. 118:1984–1991. 2006. View Article : Google Scholar : PubMed/NCBI | |
Chaturvedi AK: Epidemiology and clinical aspects of HPV in head and neck cancers. Head Neck Pathol. 6 Suppl 1:S16–S24. 2012. View Article : Google Scholar : PubMed/NCBI | |
De Petrini M, Rittà M, Schena M, Chiusa L, Campisi P, Giordano C, Landolfo V, Pecorari G and Landolfo S: Head and neck squamous cell carcinoma: Role of the human papillomavirus in tumour progression. New Microbiol. 29:25–33. 2006.PubMed/NCBI | |
Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, et al: EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 26:3128–3137. 2008. View Article : Google Scholar : PubMed/NCBI | |
Mellin H, Friesland S, Lewensohn R, Dalianis T and Munck-Wikland E: Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. International journal of cancer. Int J Cancer. 89:300–304. 2000. View Article : Google Scholar : PubMed/NCBI | |
Schwartz SR, Yueh B, McDougall JK, Daling JR and Schwartz SM: Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-. Head Neck Surg. 125:1–9. 2001. View Article : Google Scholar |